蠲逆清中饮治疗脾胃湿热型反流性食管炎的临床研究
|
摘要
目的:观察蠲逆清中饮治疗脾胃湿热型反流性食管炎(reflux esophagitis, RE)的临床疗效,并从理论和临床研究两个方面探讨蠲逆清中饮治疗RE的机制。方法:临床选择符合纳入标准的RE患者60例,随机分为两组,治疗组(30例)给予蠲逆清中饮水煎剂,对照组(30例)给予胃力康颗粒(四川宝光药业股份有限公司生产),观察两组的临床疗效。结果:临床研究显示,治疗组治愈9例,显效16例,有效4例,愈显率(痊愈+显效率)为83.33%,总有效率为96.67%。对照组临床痊愈4例,显效4例,有效14例,愈显率为26.67%,总有效率为73.33%。治疗组胃镜疗效总有效率96.67%,对照组为73.33%。治疗组显著优于对照组(愈显率比较P<0.01,总有效率比较P<0.05,胃镜疗效总有效率比较P<0.05)。治疗组在胃镜疗效积分与中医证侯总积分和消除或改善泛酸、烧心、胸膈满闷、胸痛、纳差以及口苦口粘和嗳气等症状上,疗效优于对照组。结论:蠲逆清中饮是治疗脾胃湿热型RE的有效方剂,其机理可能与调节胃食管运动,改善食管下括约肌功能,以及对胃肠激素的调节和抗炎作用等有关。
Objectiv:To observe the clinical curative effect of Juan Ni Qing Zhong Yin on reflux esophagitis of Damp Heat in Spleen and Stomach and explore the mechanism of which from theoretical and clinical aspects.Methods:60 cases with reflux esophagitis were divided into two groups at random:the treatment group (30 cases)and the control group (30cases).The former was given Juan Ni Qing Zhong Yin while the latter was given Wei Li Kang Ke Li.Symptoms and signs of each group were observed before and after the treatment,including gastroscope observing . Results:After one course of treatment,significant difference was apparent in the clinical effects;In the treatment group,9 cases recovered and 16 cases significantly improved,(thus the effectual rate is 83.33%),4 cases improved. The total effective rate in the treatment group is 96.67%.The effective rate of gastroscope observing was 96.67%.
In the control group 4 cases recovered and 4 cases significantly improved,(thus the effectual rate is 26.67%),14 cases improved.The total effective rate in the control group is 73.33%. The effective rate of gastroscope observing was 73.33%.There were statistically significant differences in the total effective rate between the treatment group and control guoup(P<0.05).The effective rate from the treatment group is clearly superior. Conclusions:Juan Ni Qing Zhong Yin is an effective drug of treating reflux esophagitis of Damp Heat in Spleen and Stomach which Mechanism might have relations with accommodating gastrointestinal motility,improving the function of lower esophageal sphincter,Anti-virus and adjusting the hormone of stomach intestine.
Objectiv:To observe the clinical curative effect of Juan Ni Qing Zhong Yin on reflux esophagitis of Damp Heat in Spleen and Stomach and explore the mechanism of which from theoretical and clinical aspects.Methods:60 cases with reflux esophagitis were divided into two groups at random:the treatment group (30 cases)and the control group (30cases).The former was given Juan Ni Qing Zhong Yin while the latter was given Wei Li Kang Ke Li.Symptoms and signs of each group were observed before and after the treatment,including gastroscope observing . Results:After one course of treatment,significant difference was apparent in the clinical effects;In the treatment group,9 cases recovered and 16 cases significantly improved,(thus the effectual rate is 83.33%),4 cases improved. The total effective rate in the treatment group is 96.67%.The effective rate of gastroscope observing was 96.67%.
In the control group 4 cases recovered and 4 cases significantly improved,(thus the effectual rate is 26.67%),14 cases improved.The total effective rate in the control group is 73.33%. The effective rate of gastroscope observing was 73.33%.There were statistically significant differences in the total effective rate between the treatment group and control guoup(P<0.05).The effective rate from the treatment group is clearly superior. Conclusions:Juan Ni Qing Zhong Yin is an effective drug of treating reflux esophagitis of Damp Heat in Spleen and Stomach which Mechanism might have relations with accommodating gastrointestinal motility,improving the function of lower esophageal sphincter,Anti-virus and adjusting the hormone of stomach intestine.
引文
[1] Tew S,Jamieson GG,Pilowsky I,et al. The illness behavior of patients with gastroesphageal reflux disease with andwithout endoscopic esophagitis [J].Dis Esophagus,1997,10(1):9～15.
[2] Cameron AJ Epidemioloy of columnal-lined esophagus and ade-nocacinoma gastro-enterol Chin North Am,1997,36:487～49.
[3]潘国宗,许国铭,郭慧平,等.北京上海胃食管反流症状的流行病学调查[J].中华消化杂志,1999,19:223～226.
[4]王进海,罗金燕.胃食管反流病流行病学及临床研究[J].基础医学与临床,2001, 21(增刊):45.
[5]周丽雅,林三仁,等.山东地区农民人群糜烂性反流性食管炎的发病研究[J].中华消化内镜杂志,2005,22,(2):101～102.
[6]叶任高主编.内科学. 5版.北京:人民卫生出版社,2000:381～386.
[7]田升,邹晓平,邹多武,等.反流性食管炎流行率和危险因素分析[J].临床消化道杂志,2004,16:136～137.
[8] Mantynen T,FarkkilaM,Kunnamo I,et al. The impact of up-per GI endoscopy referral volume on the diagnosis of gastroe-sophageal reflux disease and its complications:a 1-year cross-sectional study in a referral area with 260,000 inhabitants[J].Am J Gastroenterol,2002,97:2524～2525.
[9]王睿,贺佳.胃食管反流病的流行病学研究进展[J].第二军医大学学报,2006 ,27(7):733～734.
[10]中华医学会消化内镜学会中华消化内镜杂志编辑部.反流性食管病(炎)诊断.中华消化内镜杂志,1999,16(6):326.
[11]郑筱萸.中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002:135.
[12]郑筱萸.中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002:371～372.
[13] FassR. Gastroesophageal reflux disease revisited. GastroenterolClinNorthAm,2002,31(suppl4): S1～10.
[14]徐平如,李俊达,吴庆禧.胃食管反流病与幽门螺杆菌感染604例的相关性分析[J].河北医学, 2002(24): 463～464.
[15]陈世耀,马丽黎,刘天舒,等.幽门螺杆菌感染与反流性食管炎(一项病例对照研究) [J].复旦学报(医学版),2005, 32(3):343～346.
[16] Carmona-SanchezR , Navarro-CanoG. Prevalence ofhelicobacter pylori infection in patients with reflux esophagitis.Acase- control study[ J]. Rev GastroenterolMex,2003(68):23～28.
[17] Wong WM,Lai KC,Hui WM,et al.Am J Gastroenterol,2004;99:2088～2093.
[18]汤玉茗.胃食管反流病发病机制若干进展.国际消化病杂志,2006;26:96～97.
[19] Chrysos E,Prokopakis G,Athanasakis E,et al. Arch Surg,2003;138:241～246.
[20] Simren M,Silny J,Holloway R,et al.Gut,2003;52:784-790[19]Calabrese C,Fabbri A,Bortolotti M,et al. Aliment Pharmacol Ther,2003;18:525～532.
[21]魏良洲主编.胃食管反流病.北京.人民军医出版社,2004.9:79～80..
[22] Wise J,Conklin JL. Curr Gastroenterol Rep,2004;6:213～219.
[23] Wong WM,Lam KF,Cheng C World J Gastroenterol,2004;10:707～712.
[24] Naliboff BD,Mayer M,Fass R,et al. Psychosom Med,2004;66:426～434.
[25]杨云生,孙刚.反流性食管炎内镜诊断和评价.临床消化杂志,2006.18:134～135.
[26]中国胃食管反流病研究协作组.反流性疾病问卷在胃食管反流病诊断中的价值中华消化内镜杂志.2003,23:651～652.
[27]许洪伟,张安忠.胃食管反流病的内科治疗[J].山东医药, 2002, 42(13): 56～57.
[28]张澍田,李巍.胃食管反流病诊治进展.中华消化内镜杂志,2006,23:1～2.
[29] Lidums I , Lehmann A , Checklin H , etal·Control of transientloweresophageal sphincter relaxation and reflux by the CABAB agonistBaclofen in normal subject[J]. Gastroenterology,2000,118(1):7～13.
[30] TrudgillNJ,Hussain FN,MoustafaM,et a.l The effect of chole-cysto kinin antagonism on postprandial lower oesophageal sphincterfunction in asymptomatic volunteers and patientswith reflux disease.Aliment Pharmacol Ther,2001,15:1357～1364.
[31] Inadomi JM,Jamal R,Murata GH,etal·Step~down management ofGastroesopha-geal reflux disease[J]. Gastroenterology,2001, 121(5):1095～1100.
[32]兰索拉唑协作组.小剂量兰索拉唑维持治疗反流性食管炎多中心临床研究[J].基础医学与临床,2001,21(Suppl)∶S39.
[33] Thjodleifsson B,Beker JA,Dekkers C,etal Rabeprazole versus omprazole inpreventing relapse of erosive or ulcerative gastroesophageal reflux disease,a double blind,multicenter,European trial[J].Dig Dis Sci,2000,45(5):845～853.
[34] Inadomi JM On demand and intermittent therapy for gastroesophageal reflux disease :economic considerations[J]. Pharmacoeconomics,2002,20(9):565～576.
[35]冯桂建,胡伏莲.胃食管反流病的内科治疗进展[J].中国新药杂志,2003, 12(6):410～415.
[36]尹建明,王敏,张岑,等.奥美拉唑联合多潘立酮递减法治疗反流性食管炎疗效观察[ J].临床荟萃, 2006,21(4):268.
[37] AnneseV,CalettiG,Cipolletta L, et a.l Endoscopic treatment ofgastroes-ophageal reflux disease. Endoscopy,2005,37:470～478.
[38]张静祎.胃食管反流病的内镜治疗.中华消化内镜杂志,2006,23:74～75
[39]陈蔚文.吞酸证新议[J].新中医,1996,19(10):7.
[40]黄贤樟,邝卫红.反流性食管炎的中医病机及临床治疗探讨[J].新中医,1998,30(2):3～5.
[41]奥井由佳.半夏对大鼠迷走神经胃支传出活动的激活作用[J].国外医学.中医中药分册,1995,17(4):30.
[42]王光德,杨旭东.半夏的药理[J].国外医学·中医中药分册,1985,7(5):24.
[43]刘守义,尤春来.半夏抗溃疡作用机理的实验研究[J].辽宁中医杂志,1992, (10):42.
[44]吴皓,蔡宝昌.半夏姜制对动物胃肠道功能的影响[J].中国中药杂志,1994, 19(9):535.
[45]赵晓洋,田家琦.五味子、半夏等几种中药抗真菌作用的初步观察[J].哈尔滨医科大学学报,1991,25(2):118.
[46]鲁西,林上奇.脑CT增强扫描应用姜半夏预防造影剂副反应[J].中国中西医结合杂志,1992,(5):299.
[47]侯家玉主编.中药药理学.北京.中国中医药出版社,2002,8:109～110.
[48]侯家玉主编.中药药理学.北京.中国中医药出版社,2002,8:41～42.
[49]张明发,沈雅琴.小蘖碱的抗腹泻和抗炎作用.中国药理学报,1989,10(2):174.
[50]黄启荣.黄连黄柏抗盐酸-乙醇溃疡作用及其作用成分.国外医学.中医中药分册,1988,10(1):43.
[51]舒华,向丽华.黄连药理作用及临床应用.甘肃中医,2004,17:5～6.
[52]张明发,苏晓玲,朱自平.天然产物研究与开发,1990,2(4):59.
[53]张明发,沈雅琴,许青嫒.中药材,1991,14(3):39.
[54]邱赛红,窦昌贵.中药药理与临床,1988,4(3):9.
[55]张明发,范培荣.陕西中医,1989,10(5):231.
[56]邱赛红,陈立峰,柳克林,等.吴茱萸水煎剂对大鼠胃肠功能影响[J〕.中药药理与临床,1988,4(3):9.
[57]王建华.常用中药材品种整理和质量研究.1990:91.
[58]梅全喜,毕焕新.现代临床中药学[M].北京:中国中医药出版社,1998,166.
[59]况玲.枳实对绵羊小肠电活动的影响[J].中医药研究,1997,13(3):49～50.
[60]王翠芬,杨德治,魏义全,等.枳实对大鼠胃肠电活动影响的初步研究[J].东南大学学报,2001,20(3):153～154.
[61]胡盛珊,王大元,邱萍,等.枳实、枳壳挥发油对动物胃肠道的作用.江西医药,1992;27(3):158.
[62]赵本树,吕金梁,张庭广.胃特灵片的抗溃疡作用[J].中国中药杂志,1990,15,(6):50.
[63]叶华.福建中医药,1992,23(2):61.
[64]黄哲元.海洋药物学概论.福州:福建中医学院中药系,1987:33.
[65]方尔笠,顾洛,田苏平,等.海螵蛸防治胃溃疡作用的机理探讨[J].中国中西医结合杂志,1994,14(2):101.
[66]张明发,沈雅琴,朱自平,等.辛温(热)合归脾胃经中药药性研究(Ⅳ)镇痛作用[J].中药药理与临床, 1996,12(4):1～4.
[67]张明发,沈雅琴,朱自平,等.辛温(热)合归脾胃经中药药性研究(Ⅲ)抗炎作用[J].中药药理与临床, 1998,14(6):12～16.
[68]张明发,沈雅琴,朱自平,等.辛温(热)合归脾胃经中药药性研究(Ⅱ)抗溃疡作用[J].中药药理与临床, 1997,13(4):1～4.
[69]黄玲,黄萍,王建华,等.中药药理与临床,1991;7(3)∶8.
[70]李延斌.蒲公英药理研究新进展,中国中医药报.2007,7(007):1.
[71]遵义医学院急腹症研究组.新医药学杂志,1975,(10):36.
[72]俞琦,田维毅.合欢皮饮抗炎及抗菌作用的初步研究[J]遵义医学院学报, 2005,(02).
[73]田维毅,尚丽江,白惠卿,等.合欢皮乙醇提取物对荷瘤小鼠IL-2生物活性的影响.贵州医药,2002,26(5):392.
[1]叶庆琏,蒙木荣,臧知明.扶脾抑肝法治疗慢性反流性食管炎32例.中医杂志,2004,45(2):137.
[2]高祥华.反流性食管炎的中医病机及辨治探讨.吉林中医药,2004,24(3):15～16.
[3]车宇光,孙敏娴.自拟方治疗反流性食管炎45例.中国中医急症杂志,2006,15(12):1403.
[4]王唏星,李延荃,肖汉玺.从肝论治反流性食管炎经验[J].中国中西医结合脾胃杂志, 2000,8(1):38.
[5]张琼英.徐福音教授治疗反流性食管炎经验[J].中国中西医结合脾胃杂志, 2000,8(1):3.
[6]李坤.降逆汤治疗胃食管反流病45例[J].中国中西医结合脾胃杂志, 2000, 8(2):115.
[7]刘小北.清降汤加减治疗胃食管反流病[ J].中国医药学报,1999,14(6):53.
[8]蒋红玉,刘安国.常见消化系统疾病的中医治疗[M].北京:北京医科大学中国协和医科大学联合出版社,1997.2.
[9]江作霖.反流性食管炎证治经验[J].中国中西医结合脾胃杂志,1998,6(1): 47.
[10]陈江宁,涂洁.辨证治疗反流性食管炎102例.江苏中医药,1999,20(12):24.
[11]林小武.辨证治疗反流性食管炎48例.四川中医,1999,17(9):23.
[12]田波.中医辨治反流性食管炎.甘肃中医学院学报,2000,17(4):20～21.
[13]李文.反流性食管炎的中医辨治体会.云南中医中药杂志,2002,23(2):13.
[14]刘国凤.辨证治疗反流性食管炎39例.中国中医急症杂志,2004,13(3):144.
[15]杨丽蓉.辨证论治反流性食管炎48例.江西中医药,2005,36(9):33～34.
[16]陈洪利.辨证分型治疗反流性食管炎100例观察.实用中医内科杂志,2006, 20(3):259～260.
[17]刘群.蔡淦治疗胃食管反流性疾病经验[J].上海中医药杂志, 2005,39(8): 27～28.
[18]杜琳,郭琳.单兆伟治疗胃食管反流病经验[J].山东中医杂志, 2004, 23(4): 238～239.
[19]吕立刚,沙宝瑜.疏肝和胃降逆汤治疗胆汁反流性胃炎40例[J].陕西中医, 2005,26 (1):27～28.
[20]黄彬.半夏泻心汤加减治疗返流性食管炎临床观察[J].辽宁中医杂志,1999, 26 (10):459.
[21]赵立群,朱振铎,刘同亭,等.疏肝和胃法治疗老年人返流性食管炎的临床研究[J]山东中医药大学学报,1999,23 (6):439～440.
[22]蔡慧卿.食管炎1号方治疗反流性食管炎疗效观察.辽宁中医杂志,2004,31(4): 305.
[23]高宇华.小陷胸汤加味治疗反流性食管炎34例临床观察,四川中医,2006,24(9):568.
[24]马谊.小柴胡汤加味治疗反流性食管炎36例疗效观察.云南中医药杂志,2005, 26(1):20.
[25]李胜明.半夏泻心汤治疗反流性食管炎45例疗效观察.四川中医,2005,23(2): 57.
[26]程艳梅,朱生樑，马淑颖，等.通降和胃方对大鼠混合反流性食管炎食管上皮的影响.山西中医,2005,21(1):46-48.
[27]唐旭东,吴红梅,王志斌,等.通降颗粒对大鼠实验性反流性食道炎的作用机制的研究.中国中药杂志,2006,31(2):136-138.
[28]唐旭东,吴红梅,王志斌,等.通降颗粒对大鼠实验性反流性食管炎的疗效评价研究.中国中西医结合杂志,2006,26(9):818-821.
[29]王洪俊,崔烜,袁红霞.电针对反流性食管炎模型大鼠血浆胃动素水平的影响.天津中医,2004,21(1):58.
[2] Cameron AJ Epidemioloy of columnal-lined esophagus and ade-nocacinoma gastro-enterol Chin North Am,1997,36:487～49.
[3]潘国宗,许国铭,郭慧平,等.北京上海胃食管反流症状的流行病学调查[J].中华消化杂志,1999,19:223～226.
[4]王进海,罗金燕.胃食管反流病流行病学及临床研究[J].基础医学与临床,2001, 21(增刊):45.
[5]周丽雅,林三仁,等.山东地区农民人群糜烂性反流性食管炎的发病研究[J].中华消化内镜杂志,2005,22,(2):101～102.
[6]叶任高主编.内科学. 5版.北京:人民卫生出版社,2000:381～386.
[7]田升,邹晓平,邹多武,等.反流性食管炎流行率和危险因素分析[J].临床消化道杂志,2004,16:136～137.
[8] Mantynen T,FarkkilaM,Kunnamo I,et al. The impact of up-per GI endoscopy referral volume on the diagnosis of gastroe-sophageal reflux disease and its complications:a 1-year cross-sectional study in a referral area with 260,000 inhabitants[J].Am J Gastroenterol,2002,97:2524～2525.
[9]王睿,贺佳.胃食管反流病的流行病学研究进展[J].第二军医大学学报,2006 ,27(7):733～734.
[10]中华医学会消化内镜学会中华消化内镜杂志编辑部.反流性食管病(炎)诊断.中华消化内镜杂志,1999,16(6):326.
[11]郑筱萸.中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002:135.
[12]郑筱萸.中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002:371～372.
[13] FassR. Gastroesophageal reflux disease revisited. GastroenterolClinNorthAm,2002,31(suppl4): S1～10.
[14]徐平如,李俊达,吴庆禧.胃食管反流病与幽门螺杆菌感染604例的相关性分析[J].河北医学, 2002(24): 463～464.
[15]陈世耀,马丽黎,刘天舒,等.幽门螺杆菌感染与反流性食管炎(一项病例对照研究) [J].复旦学报(医学版),2005, 32(3):343～346.
[16] Carmona-SanchezR , Navarro-CanoG. Prevalence ofhelicobacter pylori infection in patients with reflux esophagitis.Acase- control study[ J]. Rev GastroenterolMex,2003(68):23～28.
[17] Wong WM,Lai KC,Hui WM,et al.Am J Gastroenterol,2004;99:2088～2093.
[18]汤玉茗.胃食管反流病发病机制若干进展.国际消化病杂志,2006;26:96～97.
[19] Chrysos E,Prokopakis G,Athanasakis E,et al. Arch Surg,2003;138:241～246.
[20] Simren M,Silny J,Holloway R,et al.Gut,2003;52:784-790[19]Calabrese C,Fabbri A,Bortolotti M,et al. Aliment Pharmacol Ther,2003;18:525～532.
[21]魏良洲主编.胃食管反流病.北京.人民军医出版社,2004.9:79～80..
[22] Wise J,Conklin JL. Curr Gastroenterol Rep,2004;6:213～219.
[23] Wong WM,Lam KF,Cheng C World J Gastroenterol,2004;10:707～712.
[24] Naliboff BD,Mayer M,Fass R,et al. Psychosom Med,2004;66:426～434.
[25]杨云生,孙刚.反流性食管炎内镜诊断和评价.临床消化杂志,2006.18:134～135.
[26]中国胃食管反流病研究协作组.反流性疾病问卷在胃食管反流病诊断中的价值中华消化内镜杂志.2003,23:651～652.
[27]许洪伟,张安忠.胃食管反流病的内科治疗[J].山东医药, 2002, 42(13): 56～57.
[28]张澍田,李巍.胃食管反流病诊治进展.中华消化内镜杂志,2006,23:1～2.
[29] Lidums I , Lehmann A , Checklin H , etal·Control of transientloweresophageal sphincter relaxation and reflux by the CABAB agonistBaclofen in normal subject[J]. Gastroenterology,2000,118(1):7～13.
[30] TrudgillNJ,Hussain FN,MoustafaM,et a.l The effect of chole-cysto kinin antagonism on postprandial lower oesophageal sphincterfunction in asymptomatic volunteers and patientswith reflux disease.Aliment Pharmacol Ther,2001,15:1357～1364.
[31] Inadomi JM,Jamal R,Murata GH,etal·Step~down management ofGastroesopha-geal reflux disease[J]. Gastroenterology,2001, 121(5):1095～1100.
[32]兰索拉唑协作组.小剂量兰索拉唑维持治疗反流性食管炎多中心临床研究[J].基础医学与临床,2001,21(Suppl)∶S39.
[33] Thjodleifsson B,Beker JA,Dekkers C,etal Rabeprazole versus omprazole inpreventing relapse of erosive or ulcerative gastroesophageal reflux disease,a double blind,multicenter,European trial[J].Dig Dis Sci,2000,45(5):845～853.
[34] Inadomi JM On demand and intermittent therapy for gastroesophageal reflux disease :economic considerations[J]. Pharmacoeconomics,2002,20(9):565～576.
[35]冯桂建,胡伏莲.胃食管反流病的内科治疗进展[J].中国新药杂志,2003, 12(6):410～415.
[36]尹建明,王敏,张岑,等.奥美拉唑联合多潘立酮递减法治疗反流性食管炎疗效观察[ J].临床荟萃, 2006,21(4):268.
[37] AnneseV,CalettiG,Cipolletta L, et a.l Endoscopic treatment ofgastroes-ophageal reflux disease. Endoscopy,2005,37:470～478.
[38]张静祎.胃食管反流病的内镜治疗.中华消化内镜杂志,2006,23:74～75
[39]陈蔚文.吞酸证新议[J].新中医,1996,19(10):7.
[40]黄贤樟,邝卫红.反流性食管炎的中医病机及临床治疗探讨[J].新中医,1998,30(2):3～5.
[41]奥井由佳.半夏对大鼠迷走神经胃支传出活动的激活作用[J].国外医学.中医中药分册,1995,17(4):30.
[42]王光德,杨旭东.半夏的药理[J].国外医学·中医中药分册,1985,7(5):24.
[43]刘守义,尤春来.半夏抗溃疡作用机理的实验研究[J].辽宁中医杂志,1992, (10):42.
[44]吴皓,蔡宝昌.半夏姜制对动物胃肠道功能的影响[J].中国中药杂志,1994, 19(9):535.
[45]赵晓洋,田家琦.五味子、半夏等几种中药抗真菌作用的初步观察[J].哈尔滨医科大学学报,1991,25(2):118.
[46]鲁西,林上奇.脑CT增强扫描应用姜半夏预防造影剂副反应[J].中国中西医结合杂志,1992,(5):299.
[47]侯家玉主编.中药药理学.北京.中国中医药出版社,2002,8:109～110.
[48]侯家玉主编.中药药理学.北京.中国中医药出版社,2002,8:41～42.
[49]张明发,沈雅琴.小蘖碱的抗腹泻和抗炎作用.中国药理学报,1989,10(2):174.
[50]黄启荣.黄连黄柏抗盐酸-乙醇溃疡作用及其作用成分.国外医学.中医中药分册,1988,10(1):43.
[51]舒华,向丽华.黄连药理作用及临床应用.甘肃中医,2004,17:5～6.
[52]张明发,苏晓玲,朱自平.天然产物研究与开发,1990,2(4):59.
[53]张明发,沈雅琴,许青嫒.中药材,1991,14(3):39.
[54]邱赛红,窦昌贵.中药药理与临床,1988,4(3):9.
[55]张明发,范培荣.陕西中医,1989,10(5):231.
[56]邱赛红,陈立峰,柳克林,等.吴茱萸水煎剂对大鼠胃肠功能影响[J〕.中药药理与临床,1988,4(3):9.
[57]王建华.常用中药材品种整理和质量研究.1990:91.
[58]梅全喜,毕焕新.现代临床中药学[M].北京:中国中医药出版社,1998,166.
[59]况玲.枳实对绵羊小肠电活动的影响[J].中医药研究,1997,13(3):49～50.
[60]王翠芬,杨德治,魏义全,等.枳实对大鼠胃肠电活动影响的初步研究[J].东南大学学报,2001,20(3):153～154.
[61]胡盛珊,王大元,邱萍,等.枳实、枳壳挥发油对动物胃肠道的作用.江西医药,1992;27(3):158.
[62]赵本树,吕金梁,张庭广.胃特灵片的抗溃疡作用[J].中国中药杂志,1990,15,(6):50.
[63]叶华.福建中医药,1992,23(2):61.
[64]黄哲元.海洋药物学概论.福州:福建中医学院中药系,1987:33.
[65]方尔笠,顾洛,田苏平,等.海螵蛸防治胃溃疡作用的机理探讨[J].中国中西医结合杂志,1994,14(2):101.
[66]张明发,沈雅琴,朱自平,等.辛温(热)合归脾胃经中药药性研究(Ⅳ)镇痛作用[J].中药药理与临床, 1996,12(4):1～4.
[67]张明发,沈雅琴,朱自平,等.辛温(热)合归脾胃经中药药性研究(Ⅲ)抗炎作用[J].中药药理与临床, 1998,14(6):12～16.
[68]张明发,沈雅琴,朱自平,等.辛温(热)合归脾胃经中药药性研究(Ⅱ)抗溃疡作用[J].中药药理与临床, 1997,13(4):1～4.
[69]黄玲,黄萍,王建华,等.中药药理与临床,1991;7(3)∶8.
[70]李延斌.蒲公英药理研究新进展,中国中医药报.2007,7(007):1.
[71]遵义医学院急腹症研究组.新医药学杂志,1975,(10):36.
[72]俞琦,田维毅.合欢皮饮抗炎及抗菌作用的初步研究[J]遵义医学院学报, 2005,(02).
[73]田维毅,尚丽江,白惠卿,等.合欢皮乙醇提取物对荷瘤小鼠IL-2生物活性的影响.贵州医药,2002,26(5):392.
[1]叶庆琏,蒙木荣,臧知明.扶脾抑肝法治疗慢性反流性食管炎32例.中医杂志,2004,45(2):137.
[2]高祥华.反流性食管炎的中医病机及辨治探讨.吉林中医药,2004,24(3):15～16.
[3]车宇光,孙敏娴.自拟方治疗反流性食管炎45例.中国中医急症杂志,2006,15(12):1403.
[4]王唏星,李延荃,肖汉玺.从肝论治反流性食管炎经验[J].中国中西医结合脾胃杂志, 2000,8(1):38.
[5]张琼英.徐福音教授治疗反流性食管炎经验[J].中国中西医结合脾胃杂志, 2000,8(1):3.
[6]李坤.降逆汤治疗胃食管反流病45例[J].中国中西医结合脾胃杂志, 2000, 8(2):115.
[7]刘小北.清降汤加减治疗胃食管反流病[ J].中国医药学报,1999,14(6):53.
[8]蒋红玉,刘安国.常见消化系统疾病的中医治疗[M].北京:北京医科大学中国协和医科大学联合出版社,1997.2.
[9]江作霖.反流性食管炎证治经验[J].中国中西医结合脾胃杂志,1998,6(1): 47.
[10]陈江宁,涂洁.辨证治疗反流性食管炎102例.江苏中医药,1999,20(12):24.
[11]林小武.辨证治疗反流性食管炎48例.四川中医,1999,17(9):23.
[12]田波.中医辨治反流性食管炎.甘肃中医学院学报,2000,17(4):20～21.
[13]李文.反流性食管炎的中医辨治体会.云南中医中药杂志,2002,23(2):13.
[14]刘国凤.辨证治疗反流性食管炎39例.中国中医急症杂志,2004,13(3):144.
[15]杨丽蓉.辨证论治反流性食管炎48例.江西中医药,2005,36(9):33～34.
[16]陈洪利.辨证分型治疗反流性食管炎100例观察.实用中医内科杂志,2006, 20(3):259～260.
[17]刘群.蔡淦治疗胃食管反流性疾病经验[J].上海中医药杂志, 2005,39(8): 27～28.
[18]杜琳,郭琳.单兆伟治疗胃食管反流病经验[J].山东中医杂志, 2004, 23(4): 238～239.
[19]吕立刚,沙宝瑜.疏肝和胃降逆汤治疗胆汁反流性胃炎40例[J].陕西中医, 2005,26 (1):27～28.
[20]黄彬.半夏泻心汤加减治疗返流性食管炎临床观察[J].辽宁中医杂志,1999, 26 (10):459.
[21]赵立群,朱振铎,刘同亭,等.疏肝和胃法治疗老年人返流性食管炎的临床研究[J]山东中医药大学学报,1999,23 (6):439～440.
[22]蔡慧卿.食管炎1号方治疗反流性食管炎疗效观察.辽宁中医杂志,2004,31(4): 305.
[23]高宇华.小陷胸汤加味治疗反流性食管炎34例临床观察,四川中医,2006,24(9):568.
[24]马谊.小柴胡汤加味治疗反流性食管炎36例疗效观察.云南中医药杂志,2005, 26(1):20.
[25]李胜明.半夏泻心汤治疗反流性食管炎45例疗效观察.四川中医,2005,23(2): 57.
[26]程艳梅,朱生樑，马淑颖，等.通降和胃方对大鼠混合反流性食管炎食管上皮的影响.山西中医,2005,21(1):46-48.
[27]唐旭东,吴红梅,王志斌,等.通降颗粒对大鼠实验性反流性食道炎的作用机制的研究.中国中药杂志,2006,31(2):136-138.
[28]唐旭东,吴红梅,王志斌,等.通降颗粒对大鼠实验性反流性食管炎的疗效评价研究.中国中西医结合杂志,2006,26(9):818-821.
[29]王洪俊,崔烜,袁红霞.电针对反流性食管炎模型大鼠血浆胃动素水平的影响.天津中医,2004,21(1):58.